-
Cepheid’s GeneXpert system combines speed, accuracy, and simplicity to deliver PCR results anywhere testing is needed. The GeneXpert® family of systems have set a new standard in workflow flexibility, 24/7 testing accuracy, and user-friendly design — delivered in an astonishingly beautiful and compact package. The GeneXpert System is available in a two, four, 16, 48, or 80-module configuration. In addition, our CLIA-Waived GeneXpert Xpress is available for front line access and control, anywhere you need it.
-
The NEW Xpert Xpress CoV-2 plus test provides: · Fast and accurate results in as early as 20 minutes* · Three gene targets for SARS-CoV-2 as well as an optimization of N2 probes to enable more reliable virus detection · Rapid sample-to-answer testing with actionable results from a single sample
-
• Robust design with three distinct gene targets for SARS-CoV-2: N2, E, RdRP. • Accurate detection and differentiation of SARS-CoV-2, Flu A, Flu B, and RSV. Results for SARS-CoV-2 in as little as 25 minutes. • Actionable results from a single sample with less than one minute of hands-on time. • Standardization of results between the central lab and near-patient testing sites.
-
Cepheid has developed an automated molecular test for the qualitative detection of SARS-CoV-2, the virus that causes COVID-19. The test leverages the design principles of our current Xpert® Xpress Flu/RSV cartridge technology, in which multiple regions of the viral genome are targeted. The test can provide rapid detection of the current pandemic coronavirus SARS-CoV-2 in approximately 45 minutes with less than a minute of hands on time to prepare the sample. Xpert® Xpress SARS-CoV-2 can be utilized in multiple settings where actionable test results are needed to make informed treatment decisions quickly. The test delivers point-of-care results with the same level of performance seen in reference labs. The test is designed for use on Cepheid’s GeneXpert® Systems, which have a worldwide footprint of more than 23,000 placements.
-
• Detection and differentiation of flu, RSV, and COVID-19 which all present with similar symptoms • Actionable detection of SARS-CoV-2, Flu A, Flu B, and RSV in as little as 25 minutes^ • Actionable on-demand results with 1 sample collection • Optimizes GeneXpert® System module capacity by combining 2 Xpress tests into 1 • Standardization of results between the central lab and near patient testing sites
